Main content
'Not too late to review cost' of breast cancer drug Kadcyla
The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.
Duration:
This clip is from
Featured in...
![]()
Health clips
Listen to a selection of clips from recent and upcoming programmes.
More clips from Today
-
![]()
Trump targets NASA's climate research missions
Duration: 04:08
-
![]()
Could 'dark energy' unlock secrets of our universe?
Duration: 03:27
-
![]()
'Skibidi' and 'tradwife' added to Cambridge Dictionary
Duration: 03:49
-
![]()
Broccoli warning as farmers fear 'worst harvest' in decades
Duration: 04:12
